NCT00175227View on ClinicalTrials.gov

Prevention of Contrast-Induced Nephropathy

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 1996

Primary Completion Date

October 31, 2000

Conditions
Contrast-induced NephropathyAcute Renal FailureChronic Renal Failure
Interventions
DRUG

intravenous saline hydration + mannitol + furosemide

500 mls half-normal saline + 25g mannitol + 100 mg furosemide

DRUG

intravenous saline hydration

500 mls half-normal saline

Trial Locations (1)

T6G 2B7

University of Alberta Hospitals, Edmonton

All Listed Sponsors
collaborator

Alberta Heritage Foundation for Medical Research

OTHER

lead

University of Alberta

OTHER

NCT00175227 - Prevention of Contrast-Induced Nephropathy | Biotech Hunter | Biotech Hunter